Read The Chip to Understand Small Tech
As Wall Street investors evaluate their estimate of how tech stocks will perform, one factor that can surprise everyone is new science. My investment strategy over the last five years has been to put my money into "small tech". As an Ayn Rand fan, those who wish to emulate my strategy would do well to understand the exact meaning of my "small tech" choices. Though Hank Rearden was once small when Midas Mulligan chose to lend him the money for massive expansion, not all amateur investors have the stomach for the risks of a small company.The latest Second Renaissance Book that I have completed is The Chip: How Two Americans Invented the Microchip and Launched a Revolution, by T.R. Reid. I chose this book to better understand the company that I hold most of my shares in: Intel Corp. (INTC). I found the book very informative and am confident that my investment strategy is on track in selecting "small tech".
Currently, my other investment is biotech. I sold my Eli Lilly & Co. (LLY) shares before the election--cashing in on a 60% plus profit. I also unloaded my shares in AbbVie Inc. (ABBV) for a small gain. Though I am no longer a shareholder in these innovative giants, I will always be indebted to them and their bioengineers who invented the two medicines which were accepted by psychiatry as alternatives to the chemical tortures of its code. My primary reason for the two sales was the acceptance that I have made my statement of competence; and with the agreed to legacy of the Big Pharma medicines enhancing my mind, it was time to move on.
However, having invested so much into reading books on medicine and campaigning for Big Pharma and Biotech, I still wanted to be in the sector. So, I chose to keep the one best company I know of that will probably innovate "small tech" products in the long run. That company is Vertex Pharmaceuticals Inc. (VRTX). I can only hope that their research staff will read every "Father of Metachemics" containing post in this blog.
Paul Wharton
Objectivist Capitalist Medicine Promoter